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PRELIMINARY REPORT OF HIV AND Toxoplasma gondii OCCURRENCE IN 
PREGNANT WOMEN FROM MOZAMBIQUE
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SUMMARY
Toxoplasmosis, a protozoan disease, causes severe disease in fetuses during pregnancy and deadly encephalitis in HIV patients. 
There are several studies on its seroprevalence around the world, but studies focusing on African countries are limited in number and 
mostly anecdotal. We studied two groups of samples from Mozambique by ELISA, using serum samples from 150 pregnant women 
and six Cerebrospinal fluid (CSF) samples from AIDS patients with encephalitis. HIV status was confirmed, and CD4 blood counts 
were obtained from HIV-positive pregnant women. IgG seroprevalence of the group as a whole was 18.7% (28/150), with a higher 
prevalence in HIV-positive individuals compared to those who were HIV-negative (31.3%, [18/58] vs. 10.9%, [10/92]) patients. 
These data may be biased due to cumulative effects of exposition affecting disease prevalence. If corrected, this data may indicate 
an interaction of HIV and T. gondii. Prevalence of both diseases increases with age, but this is more clearly seen for toxoplasmosis 
(p < 0.005) than HIV infection, possibly explained by higher transmission of HIV after childhood. In HIV patients suffering from 
encephalitis, CSF serology showed that 33% of specific IgG CSF had a high avidity, which was in accordance with the data from 
the group of pregnant women. Lower prevalence rates of both infections in older groups could be explained by more deaths in the 
infected groups, resulting in an artificially lower prevalence. Using CD4 counts as a marker of time of HIV infection, and correcting 
for age, patients with contact with T. gondii had fewer CD4 cells, suggesting prolonged HIV disease or other causes. Toxoplasma 
IgG prevalence is higher in HIV+ groups, which could be ascribed to HIV- and T. gondii-associated risk factors, such as exposure to 
higher and more diverse social contacts. The low incidence of Toxoplasma IgG in younger age groups shows that transmission could 
be related to better access to cyst-containing meat in adulthood, as environmental transmission due to oocysts is usually blamed for 
higher incidence in children. Taken together, these data support the urgent need of research in toxoplasmosis in Africa, especially in 
the presence of HIV epidemics. 
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INTRODUCTION
Toxoplasma gondii infection occurs worldwide, and it is one of the 
most common infections in humans. The infection is mainly acquired 
by ingestion of undercooked or raw meat containing viable tissue cysts, 
or by ingestion of food and water that is contaminated with oocysts shed 
by felids (DUBEY & JONES, 2008). Although the course of the primary 
infection is usually subclinical and the vast majority of the infected human 
population remains asymptomatic, the infection can cause significant 
morbidity and mortality in certain groups (WEISS & DUBEY, 2009). 
Toxoplasmosis can cause severe disease in fetuses of acutely infected 
pregnant women (MONTOYA & REMINGTON, 2008). Additionally, the 
reactivation of latent infection occurs in immune compromised patients, 
causing life-threatening disease, especially encephalitis (PASSOS et al., 
2000). Encephalitis due to reactivated toxoplasmosis is one of the most 
common opportunistic neurological infections in AIDS patients, typically 
observed in the later stages of human immunodeficiency virus (HIV) 
infection (MASCHKE et al., 2000). Its incidence is directly related to the 
prevalence of anti-T. gondii antibodies in the general population (PASSOS 
et al., 2000). The prevalence of toxoplasmosis (between 30% and 60% in 
most countries) varies widely in different regions of the globe (TENTER 
et al., 2000). Few studies on this prevalence have been conducted in sub-
Saharan Africa (SHIMELIS et al., 2009, LINDSTRON et al., 2006) or 
in Austral Africa. Instead, studies have mostly been conducted in South 
Africa (HARI et al., 2007), where the disease was first described in the 
1950s (BECKER, 1954; FASSER, 1955). 
In Mozambique, physicians anecdotally report congenital 
toxoplasmosis or AIDS encephalitis, but the true occurrence of 
toxoplasmosis, which is currently estimated by anti-T. gondii antibodies 
in pregnant women and patients with HIV/AIDS is unknown. We believe 
that defining the occurrence of toxoplasmosis, using anti-T.gondii 
SITOE, S.P.B.L.; RAFAEL, B.; MEIRELES, L.R.; ANDRADE Jr., H.F. & THOMPSON, R. - Preliminary report of HIV and Toxoplasma gondii occurrence in pregnant women from Mozambique. 
Rev. Inst. Med. Trop. Sao Paulo, 52(6): 291-5, 2010.
292
antibodies during antenatal care in pregnant women or in AIDS patients 
in our community, would reduce the risk of treatable damage to the CNS 
and the high morbidity of this type of patient (MASCHKE et al., 2000). 
The objective of this study was to determine the occurrence of 
toxoplasmosis in samples from public health system hospitals and clinics 
from the Maputo area, by detecting T. gondii-specific IgG antibodies from 
women in the first trimester of their pregnancy, and also by titering these 
antibodies and their avidity in Cerebrospinal fluid (CSF) samples from 
AIDS patients with suspected encephalitis.
MATERIALS AND METHODS
Samples: We studied 150 serum samples from pregnant women 
seeking first trimester prenatal care. Serum samples were also tested for 
HIV infection, and CD4 counts were determined in positive samples. CSF 
from HIV-positive patients with suspected encephalitis from Hospital 
Central de Maputo, the large public health facility, were available for 
confirming Toxoplasma encephalitis using specific antibody detection 
and avidity assays. This study was performed with approval of the Ethics 
Commission of HCM and INS and informed consent was obtained from 
patients or their relatives before collection. All samples were immediately 
processed and stored at -20 °C until use.
Enzyme Linked Immunosorbent Assay (ELISA): Serum 
samples were examined by immunoenzymatic assay (ELISA) using 
the commercial kits Toxoplasma gondii IgG ELISA (TOXG-013) and 
Toxoplasma gondii IgM µ-capture ELISA (T0XM-016) (ELISA-IBL 
Imuno-Biological Laboratories®, Hamburg, Germany) to identify 
the presence of immunoglobulin IgG and IgM, according to the 
manufacturer’s instructions. 
Cerebrospinal Fluid (CSF) IgG Avidity: The IgG avidity assay was 
performed as elsewhere described (MEIRELES et al., 2004) with minor 
modifications. ELISA microplates (Multiwell plate/polystyrene, Sigma) 
were coated with 100 mL/well of a solution containing 10 mg/mL of the T. 
gondii antigen extract diluted in 6M urea pH 7.0, incubated overnight at 
4 °C and blocked for one hour at 37 °C with 2% fat free dry milk. Undiluted 
CSF was applied to two wells and incubated for one hour at 37 °C. After 
this, one well was washed with 100 mL of 6M urea pH 7.0, and incubated 
at 37 °C for 10 min. After the incubation, bound IgG was revealed by 
specific peroxidase conjugate and o-phenylenediamine. The A492nm was 
determined in the control and urea treated wells by spectrophotometry 
(Multiskan MS). The avidity of each sample was calculated as the percent 
of A492nm resistant to urea. Samples with more than 75% A492nm resistance to 
urea treatment were considered to have high avidity. Samples with control 
well values greater than the mean plus three SD of A492nm of negative wells 
were considered positive for T. gondii IgG and toxoplasmosis. 
Statistics: Comparisons of frequencies of events between groups 
were performed using two-tailed Chi-square tests. Comparisons of 
quantitative data, such as CD4+ counts, were performed using Student’s 
t-tests. Age evolution was tested using linear regression and goodness 
to fit or r2, with confidence interval comparison between slopes and 
intercepts. Differences were considered significant when the probability 
of equality was less than 0.05 (p < 0.05). We used for all calculations 
the statistical software Graph Pad Prism 5.0 (GraphPad Software, San 
Diego California USA, www.graphpad.com). 
RESULTS
We studied two groups of samples using ELISA methods. The 
populations studied included serum samples from 150 pregnant women 
from public prenatal care clinics and 6 CSF samples from AIDS patients 
with encephalitis from the “Hospital Central de Maputo”. HIV status 
was confirmed by serology, and CD4 blood counts were obtained for 
HIV-positive pregnant women. The age of the subjects ranged from 15 
to 50 years old, with an average of 32 years. 
The overall occurrence of anti-Toxoplasma IgG antibodies, as shown 
in Fig. 1, was 18.7% (28/150) with only one case (3.6%, 95% C.I. 
0.09-16) associated with anti- T. gondii IgM antibodies. Toxoplasmosis 
occurrence was more prevalent in HIV-positive patients (31.3%, 18/58), 
when compared to HIV-negative patients (10.9%, 10/92) (p < 0.005), with 
a 3.6 Odds Ratio for Toxoplasma infection in HIV-infected individuals. 
In samples from HIV patients with encephalitis, cerebrospinal fluid 
serology showed a 33% (95% CI 4-77%) occurrence of specific anti-T. 
gondii IgG of high avidity in CSF, which was expected according to the 
occurrence in this group, and based on our data from the pregnant women. 
The occurrence of both HIV or Toxoplasma infections increases with 
age, as shown in Fig. 2, but this is more clearly seen in toxoplasmosis 
(p < 0.005) than in HIV infection (p < 0.05), with similar slopes, but 
different intercepts. 
Looking for interaction between both infections, we sorted the 
patients according to HIV status to look for occurrence of Toxoplasma-
specific antibody, or according to occurrence of Toxoplasma specific 
antibody and frequency of HIV infection in age groups, as shown in 
Fig. 3. There was a clear increase of Toxoplasma occurrence according 
to age groups in both HIV-negative (Fig. 3A) and HIV-positive groups 
(Fig. 3B), but the curves were quite diverse, due to a difference in age of 
first contact with the agent. The difference in intercepts was significant (p 
< 0.004), without a difference in their slopes. Thus, HIV-infected pregnant 
women appeared to have had contact with T. gondii at lower ages than 
non-infected women, with a difference of almost 13 years, but after this, 
the increase of occurrence with age was similar for both groups. After 
sorting by occurrence of Toxoplasma-specific antibody, the occurrence 
Fig. 1 - Proportion of Toxoplasma-specific antibody detection in sera from pregnant women 
in Mozambique, in total and sorted according to HIV status, and CSF from encephalitis AIDS 
patients. Bars represent 95% confidence interval. In HIV infected women, the odds ratio for 
toxoplasma infection is 3.6 times higher. 
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of HIV infection clearly increased with age in pregnant women without 
Toxoplasma antibodies (Fig. 3C), but this was not observed in pregnant 
women with T. gondii antibodies, who presented with a higher frequency 
of HIV infection despite its age group (Fig. 3D). 
HIV evolution, as measured by CD4+ cell counts, was evident in 
the data shown in Fig. 4. The progression of HIV disease, as indicated 
by low CD4 mean counts, appears to be more intense in Toxoplasma 
infected patients. This fact is not associated with the age effect or with 
delayed HIV disease in Toxoplasma-free persons, as it was clearly seen in 
younger age groups (< 30 years old), whereas older people did not show 
the same T. gondii infection effect in their CD4+ cell counts. 
DISCUSSION
Our data concerning the frequency of anti-T. gondii antibodies was 
similar to other findings in Africa, and suffered from the same problems 
of sampling populations as similar reports (ZUMLA et al., 1991, 
LINDSTRON et al., 2006, NABIAS et al., 1998). The planning of an 
adequate and reliable search for toxoplasmosis is urgently needed in 
Africa, due to the HIV epidemic and the risk of severe lethal or disabling 
opportunistic Toxoplasma encephalitis (MAKUWA et al., 1999). 
We studied a relatively uniform population, without age differences 
and of the same ethnicity. The occurrence of both diseases increased 
with subject age, which is expected with constant exposure. This fact 
could be explained by a higher transmission of HIV during adulthood 
in our sample population. Stable or slightly lower occurrences of both 
infections in older groups could be explained by biased selection of 
non-infected survivors (resulting from death of infected patients), a 
defect of cross-sectional studies and the prevalence of HIV infection. 
HIV occurrence was higher than toxoplasmosis in our population, but 
Fig. 2 - Proportion of HIV- and Toxoplasma-specific antibody detection in sera from pregnant 
women from Mozambique, in total and sorted according to age group. 
Fig. 3 - Occurrence of HIV or toxoplasmosis in age groups, sorted for the other disease serology in pregnant women from Mozambique. A and B: Toxoplasmosis occurrence according to HIV 
status A: HIV negative samples, B: HIV positive samples. C and D: HIV occurrence according to toxoplasmosis status C: Toxoplasmosis negative samples, D: Toxoplasmosis positive samples. 
Regression was estimated as continuous lines and numbers are expressed as positive/total in each point. 
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toxoplasmosis occurrence was higher in the HIV-infected population, 
suggesting an interaction between diseases. These data could be biased 
according to the cumulative effect of deaths due to HIV that similarly 
could affect occurrence measure. This association of toxoplasmosis 
and HIV was seen elsewhere in Africa (ZUMLA et al., 1991), but there 
are few studies of the non-HIV-infected population (SHIMELIS et al., 
2009, LINDSTRON et al., 2006). We found a higher toxoplasmosis 
occurrence in the HIV-positive groups as compared to HIV-negative 
pregnant women that could be ascribed to common or associated risk 
factors for both infections, such as exposure to both sexual contacts and 
meat consumption. This fact is also shown in anti-T.gondii IgG frequency 
by age group, with a delay of toxoplasmosis risk in older groups of the 
HIV-negative population, which suggests that the transmission could 
be related to reduced exposure to cyst-containing meat in adult life, 
and not an environmental transmission due to oocysts (which is usually 
associated with a higher incidence in children) (BAHIA-OLIVEIRA 
et al., 2003). Several explanations for the interaction between both 
infections resulting in high Toxoplasma infection in HIV patients have 
been previously proposed (LIN & BOWMAN, 1992). One possibility 
is an increase in risky behavior in Toxoplasma infected individuals that 
leads to increased exposure to HIV infection. Such a change in behavior 
could be due to parasite-driven personality changes, as described in 
Toxoplasma-infected individuals in the Czech Republic (FLEGR et al., 
1996). Another plausible explanation is that Toxoplasma infection is a 
marker of exposure to risky social contacts or habits, which correlates 
with early HIV infection. The access to infected meat would be only a 
marker of migration from small isolated villages to bigger cities or the 
improvement of quality of life by better income, resulting in more social 
contacts, which could also be associated with HIV infection. 
The lower CD4 counts found in HIV patients who also presented 
with anti-T. gondii antibodies, as compared to HIV patients without 
those antibodies, suggests intense HIV disease progression in this 
group. Progression could be caused by HIV infection of more CD4 cells 
with higher viral loads and progressive disease in T. gondii chronically 
infected patients. Toxoplasma infection can promote an increase in CD4 
cells by a strong specific immune response (DENKERS & BUTCHER, 
2005), or nonspecific CD4 cell proliferation induced by toxoplasmosis 
(PURNER et al., 1998). Malaria has similar effects in HIV patients with 
more severe infections, especially in infants and pregnant women. There 
is evidence that HIV progression could be more rapid in malaria patients, 
due to increases in transient viral load in malarial bouts (REITHINGER 
et al., 2009). 
Management of HIV epidemics has been established in industrialized 
countries without frequent transmissible diseases, but must be reevaluated 
in Africa, where hyperendemic diseases such as malaria increase the 
complexity of host disease interactions that alter the immune system’s 
control strategies for all diseases (STILLWAGGON, 2009). Data obtained 
elsewhere may not apply to areas with other hyperendemic diseases 
that enhance HIV transmission or disease progression. Our preliminary 
data includes toxoplasmosis in those diseases. This perverse circuit of 
meat that can transmit Toxoplasma, thereby increasing the severity of 
HIV, and with malaria, resulting in longer life with higher viral loads 
and more transmission, increases the burden of HIV in Africa. Our data 
suggests that Toxoplasma infection could also affect HIV evolution, 
either by increasing the risk of rapid evolution of HIV infection or as an 
opportunistic infection, with disabling or lethal encephalitis.
This data supports the urgent need of research in toxoplasmosis in 
Africa, especially in the presence of HIV epidemics. The occurrence 
and peculiarities of toxoplasmosis in Mozambique revealed by this 
study emphasize the importance of increasing public awareness about 
the infection in Mozambique. Further studies of toxoplasmosis, in either 
Maputo or other areas of Mozambique, such as Chokwé and Cape 
Delgado, are needed to improve our knowledge on the risk of congenital 
toxoplasmosis and Toxoplasma encephalitis in HIV/AIDS patients. A 
program for serodiagnosis and prevention of toxoplasmosis in pregnant 
women or HIV-positive patients could reduce the burden and disabilities 
in Toxoplasma infections in Mozambique. 
RESUMO
Descrição preliminar da ocorrência de infecção pelo HIV e 
toxoplasmose em mulheres grávidas em Moçambique
Toxoplasmose, uma protozoonose, causa doença grave em fetos de 
mulheres grávidas com infecção aguda e encefalite letal em portadores 
de HIV. Apesar de muitos estudos sobre sua prevalência no Mundo, 
existem apenas alguns relatos da toxoplasmose na África Austral, 
geralmente anedóticos. Estudamos por ELISA dois grupos de amostras de 
Moçambique, usando 150 amostras de soros de mulheres grávidas e seis 
amostras de Liquido Cefalorraquidiano (LCR) de pacientes com AIDS e 
encefalite. O estado da infecção pelo HIV foi confirmado e a contagem 
de células CD4+ no sangue foi obtida das pacientes grávidas infectadas 
pelo HIV. No grupo das gestantes, IgG anti T.gondii foi encontrada em 
18.7% (28/150), mais freqüente em pacientes HIV positivas (31.3%, 
18/58) do que em HIV negativas (10.9%, 10/92). A ocorrência de ambas 
as doenças aumenta com a idade, mais claramente vista na toxoplasmose 
(p < 0.005) do que na infecção pelo HIV, devido maior transmissão do 
HIV após a infância. Na encefalite em pacientes HIV+, a sorologia do 
LCR mostrou uma ocorrência de 33% de IgG especifica de alta avidez, 
que está de acordo com a ocorrência neste grupo etário, baseado nos dados 
de nossas gestantes. A menor ocorrência de ambas as infecções em grupos 
etários mais idosos pode ser explicada pela mortalidade cumulativa por 
Fig. 4 - Blood CD4+ cells counts in HIV-pregnant women from Mozambique Maputo, 
according to toxoplasmosis serology and age groups. Open symbols = Toxoplasma negative 
Closed symbols = Toxoplasma positive. Significant differences are marked as (*) and its 
absence as (NS). Bars represent mean values and SEM.
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qualquer causa nos grupos mais idosos, resultando em menor ocorrência 
relativa. Usando as contagens de células CD4+ como marcadores da 
progressão da infecção pelo HIV e corrigindo para grupos etários, as 
gestantes HIV+ com contato com T. gondii tem menores níveis de células 
CD4+ do que as gestantes HIV+ sem contato com T.gondii. A ocorrência 
maior da toxoplasmose em gestantes HIV+ pode ser atribuída a fatores 
de risco semelhantes, como exposição a maior contato social. A baixa 
ocorrência da toxoplasmose em grupos mais jovens pode se relacionar 
com menor acesso a carne contendo cistos, já que a transmissão ambiental 
por oocistos está associada à maior incidência em crianças. Todos estes 
dados reforçam a necessidade de pesquisa da toxoplasmose na África 
Austral, especialmente na presença da epidemia pelo HIV. 
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